Tomioka Yuya, Seki Naohiko, Mizuno Keiko, Suetsugu Takayuki, Tsuruzono Kentaro, Hagihara Yoko, Kato Mayuko, Minemura Chikashi, Yonezawa Hajime, Tanaka Kentaro, Inoue Hiromasa
Department of Pulmonary Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8520, Japan.
Department of Functional Genomics, Graduate School of Medicine, Chiba University Chuo-ku, Chiba 260-8670, Japan.
Cancers (Basel). 2025 Jul 15;17(14):2348. doi: 10.3390/cancers17142348.
: To improve the prognosis of patients with lung adenocarcinoma (LUAD), revolutionary treatments for metastatic lesions are essential. : To identify genes closely involved in LUAD-cell-derived metastasis, we used RNA sequencing to generate microRNA (miRNA) expression signatures of brain metastatic lesions. Once tumor-suppressive miRNAs are identified, it will be possible to explore the numerous tumor-promoting genes that are regulated by miRNAs. : By comparison with a previously created LUAD signature, we identified several miRNAs whose expression was significantly suppressed in brain metastases. We focused on both strands of pre- ( and ), which were significantly downregulated in brain metastatic tissues, and confirmed by ectopic expression assays that both strands of pre- attenuated the aggressive phenotypes (cell proliferation, migration, and invasion) of LUAD cells. These data suggest that both strands of pre- have tumor-suppressive functions in LUAD cells. Next, we explored the target molecules that each miRNA strand regulates in LUAD cells. We identified 159 target genes regulated by and , of which 12 genes (, , , , , , , , , , , and ) affect cell cycle/cell division and the prognosis of LUAD patients. Finally, we focused on two genes, ( target) and ( target), and demonstrated their oncogenic functions and the molecular pathways they regulate in LUAD cells. : The miRNA signature derived from lung cancer brain metastasis will be a landmark in the field, and analysis of this miRNA signature will accelerate the identification of genes involved in lung cancer brain metastasis.
为改善肺腺癌(LUAD)患者的预后,针对转移病灶的革命性治疗至关重要。为了鉴定与LUAD细胞衍生转移密切相关的基因,我们使用RNA测序来生成脑转移病灶的微小RNA(miRNA)表达特征。一旦鉴定出肿瘤抑制性miRNA,就有可能探索受miRNA调控的众多肿瘤促进基因。通过与先前创建的LUAD特征进行比较,我们鉴定出几种在脑转移中表达明显受抑制的miRNA。我们聚焦于pre-(和)的两条链,它们在脑转移组织中显著下调,并通过异位表达试验证实pre-的两条链均减弱了LUAD细胞的侵袭性表型(细胞增殖、迁移和侵袭)。这些数据表明pre-的两条链在LUAD细胞中均具有肿瘤抑制功能。接下来,我们探索了每条miRNA链在LUAD细胞中调控的靶分子。我们鉴定出受和调控的159个靶基因,其中12个基因(、、、、、、、、、、和)影响细胞周期/细胞分裂以及LUAD患者的预后。最后,我们聚焦于两个基因,(靶标)和(靶标),并证明了它们在LUAD细胞中的致癌功能及其调控的分子途径。源自肺癌脑转移的miRNA特征将成为该领域的一个里程碑,对该miRNA特征的分析将加速鉴定参与肺癌脑转移的基因。